200 related articles for article (PubMed ID: 37982738)
21. Modulation of the unfolded protein response impedes tumor cell adaptation to proteotoxic stress: a PERK for hepatocellular carcinoma therapy.
Vandewynckel YP; Laukens D; Bogaerts E; Paridaens A; Van den Bussche A; Verhelst X; Van Steenkiste C; Descamps B; Vanhove C; Libbrecht L; De Rycke R; Lambrecht BN; Geerts A; Janssens S; Van Vlierberghe H
Hepatol Int; 2015 Jan; 9(1):93-104. PubMed ID: 25598862
[TBL] [Abstract][Full Text] [Related]
22. Palmitate-induced ER stress increases trastuzumab sensitivity in HER2/neu-positive breast cancer cells.
Baumann J; Wong J; Sun Y; Conklin DS
BMC Cancer; 2016 Jul; 16():551. PubMed ID: 27464732
[TBL] [Abstract][Full Text] [Related]
23. Regulation of PERK expression by FOXO3: a vulnerability of drug-resistant cancer cells.
Alasiri G; Jiramongkol Y; Zona S; Fan LY; Mahmud Z; Gong G; Lee HJ; Lam EW
Oncogene; 2019 Sep; 38(36):6382-6398. PubMed ID: 31312024
[TBL] [Abstract][Full Text] [Related]
24. Technical Advancements for Studying Immune Regulation of Disseminated Dormant Cancer Cells.
Ombrato L; Montagner M
Front Oncol; 2020; 10():594514. PubMed ID: 33251149
[TBL] [Abstract][Full Text] [Related]
25. Combined SFK/MEK inhibition prevents metastatic outgrowth of dormant tumor cells.
El Touny LH; Vieira A; Mendoza A; Khanna C; Hoenerhoff MJ; Green JE
J Clin Invest; 2014 Jan; 124(1):156-68. PubMed ID: 24316974
[TBL] [Abstract][Full Text] [Related]
26. PERK-Phosphorylated eIF2α Pathway Suppresses Tumor Metastasis Through Downregulating Expression of Programmed Death Ligand 1 and CXCL5 in Triple-Negative Breast Cancer.
Zou W; Bai Y; Wang X; Cheng K; Sun H; Zhang G; Wang X; Yang Z
Cancer Biother Radiopharm; 2017 Oct; 32(8):282-287. PubMed ID: 29053414
[TBL] [Abstract][Full Text] [Related]
27. A pre-existing population of ZEB2
Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
[TBL] [Abstract][Full Text] [Related]
28. Imaging of single cell responses to ER stress indicates that the relative dynamics of IRE1/XBP1 and PERK/ATF4 signalling rather than a switch between signalling branches determine cell survival.
Walter F; Schmid J; Düssmann H; Concannon CG; Prehn JH
Cell Death Differ; 2015 Sep; 22(9):1502-16. PubMed ID: 25633195
[TBL] [Abstract][Full Text] [Related]
29. Perk-dependent translational regulation promotes tumor cell adaptation and angiogenesis in response to hypoxic stress.
Blais JD; Addison CL; Edge R; Falls T; Zhao H; Wary K; Koumenis C; Harding HP; Ron D; Holcik M; Bell JC
Mol Cell Biol; 2006 Dec; 26(24):9517-32. PubMed ID: 17030613
[TBL] [Abstract][Full Text] [Related]
30. Kurarinone from
Nishikawa S; Itoh Y; Tokugawa M; Inoue Y; Nakashima KI; Hori Y; Miyajima C; Yoshida K; Morishita D; Ohoka N; Inoue M; Mizukami H; Makino T; Hayashi H
Molecules; 2019 Aug; 24(17):. PubMed ID: 31461933
[TBL] [Abstract][Full Text] [Related]
31. Effect of inhibition of the lysophosphatidic acid receptor 1 on metastasis and metastatic dormancy in breast cancer.
Marshall JC; Collins JW; Nakayama J; Horak CE; Liewehr DJ; Steinberg SM; Albaugh M; Vidal-Vanaclocha F; Palmieri D; Barbier M; Murone M; Steeg PS
J Natl Cancer Inst; 2012 Sep; 104(17):1306-19. PubMed ID: 22911670
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of breast cancer cell growth by methyl pyropheophenylchlorin photodynamic therapy is mediated though endoplasmic reticulum stress-induced autophagy in vitro and vivo.
Zhu J; Tian S; Li KT; Chen Q; Jiang Y; Lin HD; Yu LH; Bai DQ
Cancer Med; 2018 May; 7(5):1908-1920. PubMed ID: 29577663
[TBL] [Abstract][Full Text] [Related]
33. Hypoxic regulation of the PERK/ATF4/LAMP3-arm of the unfolded protein response in head and neck squamous cell carcinoma.
Nagelkerke A; Sweep FC; Stegeman H; Grénman R; Kaanders JH; Bussink J; Span PN
Head Neck; 2015 Jun; 37(6):896-905. PubMed ID: 24634103
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of eIF2alpha dephosphorylation maximizes bortezomib efficiency and eliminates quiescent multiple myeloma cells surviving proteasome inhibitor therapy.
Schewe DM; Aguirre-Ghiso JA
Cancer Res; 2009 Feb; 69(4):1545-52. PubMed ID: 19190324
[TBL] [Abstract][Full Text] [Related]
35. Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene.
Menendez JA; Vellon L; Lupu R
Ann Oncol; 2005 Aug; 16(8):1253-67. PubMed ID: 15870086
[TBL] [Abstract][Full Text] [Related]
36. 5-Azacytidine- and retinoic-acid-induced reprogramming of DCCs into dormancy suppresses metastasis via restored TGF-β-SMAD4 signaling.
Singh DK; Carcamo S; Farias EF; Hasson D; Zheng W; Sun D; Huang X; Cheung J; Nobre AR; Kale N; Sosa MS; Bernstein E; Aguirre-Ghiso JA
Cell Rep; 2023 Jun; 42(6):112560. PubMed ID: 37267946
[TBL] [Abstract][Full Text] [Related]
37. Corosolic acid, a natural triterpenoid, induces ER stress-dependent apoptosis in human castration resistant prostate cancer cells via activation of IRE-1/JNK, PERK/CHOP and TRIB3.
Ma B; Zhang H; Wang Y; Zhao A; Zhu Z; Bao X; Sun Y; Li L; Zhang Q
J Exp Clin Cancer Res; 2018 Sep; 37(1):210. PubMed ID: 30176898
[TBL] [Abstract][Full Text] [Related]
38. Cellular dormancy in minimal residual disease following targeted therapy.
Ruth JR; Pant DK; Pan TC; Seidel HE; Baksh SC; Keister BA; Singh R; Sterner CJ; Bakewell SJ; Moody SE; Belka GK; Chodosh LA
Breast Cancer Res; 2021 Jun; 23(1):63. PubMed ID: 34088357
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of PERK-dependent pro-adaptive signaling pathway as a promising approach for cancer treatment.
Rozpędek W; Pytel D; Dziki Ł; Nowak A; Dziki A; Diehl JA; Majsterek I
Pol Przegl Chir; 2017 Jun; 89(3):7-10. PubMed ID: 28703114
[TBL] [Abstract][Full Text] [Related]
40. PERK Regulates Glioblastoma Sensitivity to ER Stress Although Promoting Radiation Resistance.
Dadey DYA; Kapoor V; Khudanyan A; Thotala D; Hallahan DE
Mol Cancer Res; 2018 Oct; 16(10):1447-1453. PubMed ID: 29991528
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
